Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspase
Authors:
Open Access
- 10 September 2010
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 18 (3) , 405-414
Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cancer therapeutic agent with cancer-selective apoptogenic activity. It evokes the canonical caspase-mediated cell death pathway through death-inducing signaling complex (DISC) formation. We identified that Peroxiredoxin 6 (Prx6) interacts with caspase-10 and caspase-8 via the death effector domain (DED). Prx6 suppresses TRAIL-mediated cell death in human cancer cells, but not that induced by intrinsic apoptosis inducers such as etoposide, staurosporine, or A23187. Among Prx1–6 members, only Prx6 binds to DED caspases and is most effective in suppressing TRAIL or DED caspase-induced cell death. The antiapoptotic activity of Prx6 against TRAIL is not likely associated with its peroxidase activity but is associated with its ability to bind to DED caspases. Increased expression of Prx6 enhances the binding of Prx6 to caspase-10 but reduces TRAIL-induced DISC formation and subsequently caspase activation. Interestingly, Prx6 is highly upregulated in metastatic gastric cancer cells, which are relatively resistant to TRAIL as compared with primary cancer cells. Downregulation of Prx6 sensitizes the metastatic cancer cells to TRAIL-induced cell death. Taken together, these results suggest that Prx6 modulates TRAIL signaling as a negative regulator of caspase-8 and caspase-10 in DISC formation of TRAIL-resistant metastatic cancer cells.Keywords
This publication has 40 references indexed in Scilit:
- Direct Binding of Fas-associated Death Domain (FADD) to the Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor DR5 Is Regulated by the Death Effector Domain of FADDJournal of Biological Chemistry, 2004
- Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growthProceedings of the National Academy of Sciences, 2004
- Mice with Targeted Mutation of Peroxiredoxin 6 Develop Normally but Are Susceptible to Oxidative StressJournal of Biological Chemistry, 2003
- Caspase Activity Is Required for Stimulated B Lymphocytes to Enter the Cell CycleThe Journal of Immunology, 2003
- Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunityGenes & Development, 2003
- Metastasis suppressors alter the signal transduction of cancer cellsNature Reviews Cancer, 2003
- Caspase‐10 is recruited to and activated at the native TRAIL and CD95 death‐inducing signalling complexes in a FADD‐dependent manner but can not functionally substitute caspase‐8The EMBO Journal, 2002
- Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiencyNature, 2002
- Inactivating mutations of CASP10 gene in non-Hodgkin lymphomasBlood, 2002
- Establishment and characterization of human gastric carcinoma cell linesInternational Journal of Cancer, 1997